CAS 1627503-67-6

LDN-214117

Description:

LDN-214117, with the CAS number 1627503-67-6, is a chemical compound that has garnered attention in the field of medicinal chemistry, particularly for its potential therapeutic applications. It is characterized as a selective inhibitor of certain enzymes, which may play a role in various biological pathways. The compound is often studied for its effects on cellular processes, including inflammation and cell signaling. LDN-214117 is typically evaluated in preclinical studies to assess its efficacy and safety profile, as well as its pharmacokinetic properties. Its molecular structure and functional groups contribute to its biological activity, making it a subject of interest for researchers exploring new treatments for diseases. As with many compounds in drug development, understanding its mechanism of action, potential side effects, and interactions with other biological molecules is crucial for advancing its therapeutic potential. Further research is necessary to fully elucidate its characteristics and applications in clinical settings.

Formula: C₂₅H₂₉N₃O₃

Synonyms:

• CS-1539
• 1-[4-[6-Methyl-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenyl]piperazine
• LDN-214117
• 1-(4-(6-methyl-5-(3,4,5-trimethoxyphenyl)pyridin-3-yl)phenyl)piperazine
• LDN-214117 USP/EP/BP
• LDN-214117;LDN214117
• Piperazine, 1-[4-[6-methyl-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenyl]-

Piperazine, 1-[4-[6-methyl-5-(3,4,5-trimethoxyphenyl)-3-pyridinyl]phenyl]-

CAS: 1627503-67-6

Formula: C₂₅H₂₉N₃O₃

Purity: 98%

Molecular weight: 419.5161

Ref: IN-DA001TE2

LDN-214117

CAS: 1627503-67-6

LDN-214117

Purity: ≥98%

Molecular weight: 419.52g/mol

Ref: 54-BUP09712

LDN-214117

CAS: 1627503-67-6

LDN-214117 is a potent and selective ALK2 inhibitor.

Formula: C₂₅H₂₉N₃O₃

Purity: 98% - 99.82%

Color and Shape: Solid

Molecular weight: 419.52

Ref: TM-T1944

LDN 214117

CAS: 1627503-67-6

LDN 214117 is a small molecule that has been shown to inhibit the activity of a variety of receptors including G protein-coupled receptors, tyrosine kinase receptors, and chemokine receptors. LDN 214117 binds to the ligand binding site of these receptors and blocks signal transduction. LDN 214117 is not active against mesenchymal stem cells or epidermal growth factor receptor (EGFR) expressing cancer cells, which may be due to its low expression in these cells. This drug has also been shown to have pharmacokinetic properties that allow for oral administration.

Formula: C₂₅H₂₉N₃O₃

Purity: Min. 95%

Molecular weight: 419.52 g/mol

Ref: 3D-CQC50367